Title |
Gadolinium-based contrast agents in pediatric magnetic resonance imaging
|
---|---|
Published in |
Pediatric Radiology, April 2017
|
DOI | 10.1007/s00247-017-3806-0 |
Pubmed ID | |
Authors |
Eric M. Gale, Peter Caravan, Anil G. Rao, Robert J. McDonald, Matthew Winfeld, Robert J. Fleck, Michael S. Gee |
Abstract |
Gadolinium-based contrast agents can increase the accuracy and expediency of an MRI examination. However the benefits of a contrast-enhanced scan must be carefully weighed against the well-documented risks associated with administration of exogenous contrast media. The purpose of this review is to discuss commercially available gadolinium-based contrast agents (GBCAs) in the context of pediatric radiology. We discuss the chemistry, regulatory status, safety and clinical applications, with particular emphasis on imaging of the blood vessels, heart, hepatobiliary tree and central nervous system. We also discuss non-GBCA MRI contrast agents that are less frequently used or not commercially available. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 5 | 71% |
Norway | 1 | 14% |
United Kingdom | 1 | 14% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 5 | 71% |
Scientists | 1 | 14% |
Practitioners (doctors, other healthcare professionals) | 1 | 14% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 1% |
Unknown | 73 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 14 | 19% |
Other | 10 | 14% |
Professor | 7 | 9% |
Student > Bachelor | 6 | 8% |
Researcher | 6 | 8% |
Other | 13 | 18% |
Unknown | 18 | 24% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 22 | 30% |
Chemistry | 13 | 18% |
Nursing and Health Professions | 5 | 7% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 3% |
Biochemistry, Genetics and Molecular Biology | 2 | 3% |
Other | 7 | 9% |
Unknown | 23 | 31% |